-
481
Validation of hyperthermia as an enhancer of chemotherapeutic efficacy: insights from a bladder cancer organoid model
Published 2024-12-01Subjects: “…Hyperthermia chemotherapy…”
Get full text
Article -
482
Endometrial Carcinoma Presenting with an Isolated Osseous Metastasis: A Case Report
Published 2022-03-01Subjects: Get full text
Article -
483
A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1
Published 2025-02-01Subjects: “…chemotherapy…”
Get full text
Article -
484
Development and validation of a food-related quality of life questionnaire (CANUT-QVA) for cancer patients
Published 2025-02-01Subjects: Get full text
Article -
485
-
486
Bibliometric analysis of laryngeal cancer treatment literature (2003–2023)
Published 2025-01-01Subjects: Get full text
Article -
487
New insight in immunotherapy and combine therapy in colorectal cancer
Published 2025-01-01Subjects: Get full text
Article -
488
David Slays Goliath: Exceptional Efficacy of Oral Vinorelbine in Conquering Metastatic Finger Angiosarcoma
Published 2024-01-01Subjects: Get full text
Article -
489
The Efficacy of Paxman Scalp Cooling System in Preventing Hair Loss in Breast Cancer Patients Receiving Chemotherapy in Western India – Multi-centre Retrospective Cohort Study
Published 2024-01-01“…Aim: Chemotherapy-induced alopecia (CIA) is the most common side effect of systemic treatment in breast cancer patients. …”
Get full text
Article -
490
The Value of Combined Large Format Histopathology Technique to Assess the Surgically Removed Breast Tissue following Neoadjuvant Chemotherapy: A Single Institution Study of 40 Cases
Published 2012-01-01“…Historically, neoadjuvant chemotherapy has been used to treat patients with advanced breast disease in an attempt to convert them into candidates for breast conservation surgery. …”
Get full text
Article -
491
-
492
-
493
Neoadjuvant adebrelimab combined with chemotherapy (cisplatin/carboplatin and etoposide) for limited-stage small-cell lung cancer: a study protocol of phase 2 trial (NIUS)
Published 2025-01-01“…To this end, we plan to conduct a study on adebrelimab in combination with chemotherapy for the neoadjuvant treatment of limited-stage SCLC.Methods and analysis This will be a single-arm, prospective study. …”
Get full text
Article -
494
MRI-based deep learning and radiomics for predicting the efficacy of PD-1 inhibitor combined with induction chemotherapy in advanced nasopharyngeal carcinoma: A prospective cohort study
Published 2025-02-01“…Background: An increasing number of nasopharyngeal carcinoma (NPC) patients benefit from immunotherapy with chemotherapy as an induction treatment. Currently, there isn't a reliable method to assess the efficacy of this regimen, which hinders informed decision-making for follow-up care. …”
Get full text
Article -
495
When specific exercise is more effective than medication - Sensorimotor training is currently the most promising option to treat and prevent chemotherapy-induced peripheral neuropathy (CIPN).
Published 2025-01-01“… Introduction Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and clinically relevant adverse effect of chemotherapy, negatively impacting patient quality of life. …”
Get full text
Article -
496
Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy-Treated Node-Negative Breast Cancer patients aged <55 years
Published 2007-01-01“…Material and Methods: Prognostic comparison of Her2Neu, p110alpha (PIK3CA), Akt, mTOR, PTEN, MAI and cell-cycle regulators in 125 LNneg patients aged <55 years with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-based adjuvant systemic chemotherapy. Results: Twenty-one (17%) patients developed distant metastases = DMs (median follow-up: 134 months). p110alpha correlated (p = 0.01) with pAkt but only in PTEN-negatives; pAkt correlated (p = 0.02) with mTOR. …”
Get full text
Article -
497
Prevalence, intensity and risk factors of soil-transmitted helminthiasis after five effective rounds of preventive chemotherapy across three implementation units in Ondo State, Nigeria.
Published 2025-01-01“…<h4>Background</h4>Routine epidemiological data are essential for monitoring the effectiveness of preventive chemotherapy (PC), optimizing resource allocation, and addressing the evolving needs in the elimination of soil-transmitted helminthiasis (STH). …”
Get full text
Article -
498
-
499
Promising Remission with Reduced Bevacizumab and Pembrolizumab Dosage in a Patient with AT-rich Interaction Domain 1A Mutated Ovarian Clear-cell Carcinoma Refractory to Chemotherapy
Published 2024-01-01“…Herein, we report a patient with ovarian clear-cell carcinoma refractory to platinum-based chemotherapy, who was treated with a reduced dose of bevacizumab and pembrolizumab combination therapy and achieved a complete treatment response.…”
Get full text
Article -
500